securities laws. Investors are cautioned that such statements are only predictions and speak only as of the date of this release, and the Company undertakes no duty to update. The Company's actual results in the future may differ materially from those projected in the forward-looking statements due to risks and uncertainties that exist in the Company's operations and business environment including without limitation the timing and content of purchase orders, changes in customer demands, technical difficulties, delivery delays, defaults by customers and termination for convenience of customer contracts.
ESCO, headquartered in St. Louis, is a proven supplier of special purpose utility solutions for electric, gas and water utilities, including hardware and software to support advanced metering applications and fully automated intelligent instrumentation. In addition, the Company provides engineered filtration products to the aviation, space and process markets worldwide and is the industry leader in RF shielding and EMC test products. Further information regarding ESCO and its subsidiaries is available on the Company's web site at www.escotechnologies.com.
'/>"/>SOURCE ESCO Technologies Inc. Copyright©2009 PR Newswire. All rights reserved | |
Page: 1 2 Related medicine news :1.
HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness2.
CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael3.
UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West4.
HEI, Inc. Announces Sale of RFID Division Assets5.
Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)6.
Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference7.
Z Trim Announces Revocation of Gregory Halpern Severence Agreement8.
Brooke Franchise Corporation Announces Selected July Results9.
Manor Care, Inc. Announces Record Date for Special Stockholder Meeting10.
Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)11.
Planet Technologies Announces Agreement to Acquire Antigen Laboratories